Company: INKT
Filing Date: 2025-03-18
Form Type: 10-K
Source: 0000950170-25-041379
Chunk: 10

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-03-18
Form: 10-K
Item: Item 16
Chunk 10
---
None.

89

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

    MiNK Therapeutics, Inc.

    Date: March 18, 2025
     
    By:
    /s/ Jennifer S. Buell, Ph.D.

    Jennifer S. Buell, Ph.D.

    President, Chief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ Jennifer S. Buell, Ph.D.
     
    President, Chief Executive Officer and Director 
     
    March 18, 2025

    Jennifer S. Buell, Ph.D.
     
    (Principal Executive Officer)

    /s/ Christine M. Klaskin
     
    Treasurer (Principal Financial Officer and Principal 
     
    March 18, 2025

    Christine M. Klaskin
     
    Accounting Officer)

    /s/ Garo H. Armen, Ph.D.
     
    Chairman of the Board of Directors
     
    March 18, 2025

    Garo H. Armen, Ph.D.

    /s/ Peter Behner
     
    Director
     
    March 18, 2025

    Peter Behner

    /s/ Brian Corvese
     
    Director
     
    March 18, 2025

    Brian Corvese

    /s/ Robert Kadlec, M.D.
     
    Director
     
    March 18, 2025

    Robert Kadlec, M.D.

    /s/ Barbara Ryan
     
    Director
     
    March 18, 2025

    Barbara Ryan

    /s/ Ulf Wiinberg
     
    Director
     
    March 18, 2025

    Ulf Wiinberg

90